These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26222774)

  • 1. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women.
    Lewis JR; Lim WH; Ueland T; Wong G; Zhu K; Lim EM; Bollerslev J; Prince RL
    PLoS One; 2015; 10(7):e0134266. PubMed ID: 26222774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study.
    Lewis JR; Lim WH; Zhu K; Wong G; Dhaliwal SS; Lim EM; Ueland T; Bollerslev J; Prince RL
    Am J Nephrol; 2014; 39(1):66-74. PubMed ID: 24457210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.
    Marques GL; Hayashi S; Bjällmark A; Larsson M; Riella M; Olandoski M; Lindholm B; Nascimento MM
    Sci Rep; 2021 Jan; 11(1):2473. PubMed ID: 33510348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
    J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin and osteoprotegerin/TRAIL ratio are associated with cardiovascular dysfunction and mortality among patients with renal failure.
    Kuźniewski M; Fedak D; Dumnicka P; Stępień E; Kuśnierz-Cabala B; Cwynar M; Sułowicz W
    Adv Med Sci; 2016 Sep; 61(2):269-275. PubMed ID: 27128817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up.
    Nagai K; Sairenchi T; Irie F; Watanabe H; Ota H; Yamagata K
    PLoS One; 2016; 11(6):e0156792. PubMed ID: 27272675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.
    Xiong Z; Xu H; Huang X; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):584-91. PubMed ID: 25637632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.
    Yilmaz MI; Siriopol D; Saglam M; Unal HU; Karaman M; Gezer M; Kilinc A; Eyileten T; Guler AK; Aydin İ; Vural A; Oguz Y; Covic A; Ortiz A; Kanbay M
    Calcif Tissue Int; 2016 Aug; 99(2):121-30. PubMed ID: 27016924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.
    Mok Y; Matsushita K; Sang Y; Ballew SH; Grams M; Shin SY; Jee SH; Coresh J
    PLoS One; 2016; 11(4):e0153429. PubMed ID: 27092943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of change in renal function and mortality in elderly treated hypertensive patients.
    Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year decline in estimated glomerular filtration rate associated with a higher risk of renal disease and atherosclerotic vascular disease clinical events in elderly women.
    Lim WH; Lewis JR; Wong G; Dogra GK; Zhu K; Lim EM; Dhaliwal SS; Prince RL
    QJM; 2013 May; 106(5):443-50. PubMed ID: 23407347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
    Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM;
    Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal Disease and Risks of Kidney Function Decline and Mortality in Older People: A Community-Based Cohort Study.
    Chen YT; Shih CJ; Ou SM; Hung SC; Lin CH; Tarng DC;
    Am J Kidney Dis; 2015 Aug; 66(2):223-30. PubMed ID: 25747403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.
    Collado S; Coll E; Nicolau C; Azqueta M; Pons M; Cruzado JM; de la Torre B; Deulofeu R; Mojal S; Pascual J; Cases A
    BMC Nephrol; 2017 Sep; 18(1):290. PubMed ID: 28882110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.